Literature DB >> 8801062

In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.

J L Boucher1, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger, C Mioskowski.   

Abstract

The primary metabolites of a series of unsaturated lauric acid analogs (8-, 9-, 10-, and 11-dodecenoic acids) used as radiolabeled substrates for rat liver microsomes were quantitated by TLC and reverse phase-HPLC analysis, and identified by chemical derivation and GC/MS. Isomeric epoxidodecanoic acids and omega- and (omega-1)-monohydroxydodecenoic acids were essentially the only products formed from the incubations of the unsaturated fatty acids. Rat liver microsomes predominantly oxidized the terminal carbons of all substrates, leading to omega- and (omega-1)-hydroxylated metabolites, with the exception of 11-dodecenoic acid, which was efficiently converted to the epoxide. The E and Z isomers of dodecenoic acids were metabolized with the same efficiency and gave rise to the same pattern of hydroxylated vs. epoxidized products. The hydroxylation/epoxidation ratio was directly related to the position, but not to the geometry of the double bond in the aliphatic chain. Clofibrate pretreatment of the animals resulted in a strong induction of omega-oxidation, with a decrease in the ability to catalyze epoxidation of internal olefins, whereas phenobarbital pretreatment only stimulated (omega-1)-hydroxylation without any effect on epoxidation. In contrast to higher plants in which carbon 9 is the major target, rat liver cytochromes P450 selectively carried out hydroxylation (or epoxidation) at carbons 12 and 11 of lauric acid, as well as its unsaturated isomeric analogs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801062

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  2 in total

1.  Oxidative catabolism of alpha-tocopherol in rat liver microsomes.

Authors:  H Van Houte; E De Hoffmann; P P Van Veldhoven; G P Mannaerts; H Carchon; M I Baes; P E Declercq
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

2.  Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model.

Authors:  Uzen Savas; Daniel E W Machemer; Mei-Hui Hsu; Pryce Gaynor; Jerome M Lasker; Robert H Tukey; Eric F Johnson
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.